483
Second Pharma Co., Ltd.Second Pharma Co., Ltd. – FDA 483, Aug 30, 2024
Record Details
An FDA inspection of Second Pharma Co., Ltd., an API manufacturer, revealed significant deficiencies in quality control. The firm failed to adequately monitor water for objectionable organisms, establish proper cleaning validation for shared manufacturing equipment, and thoroughly investigate out-of-specification results, including extending investigations to potentially affected batches. These issues indicate a lack of robust quality systems impacting product purity and safety.
- Company
- Second Pharma Co., Ltd.
- Inspection date
- August 30, 2024
- Product type
- drugs
View Company Profile
ID · 7360edfa-0c77-4ebb-b3f7-e1cbceabab56
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.